PBX3 and glioma: Xu et al. revealed that silencing PBX3 resulted in a significant increase in the percentage of cells in G0/G1 phases by decreasing the expression of CDKs and increasing the expression of CDKis, thereby inhibiting cell proliferation and inducing apoptosis in glioma.14